Science Explorer Interactive view Map
Company · Malvern · United States

PhaseBio Pharmaceuticals (United States)

phasebio.comROR OpenAlex
Research works
10
▲ 128% vs 2013–17
Citations
215
21.9 per fractional work
Top-10% rate
2.4%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: PhaseBio Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does PhaseBio Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Hormonal Regulation and Hypertension, Steroid Chemistry and Biochemistry, Antiplatelet Therapy and Cardiovascular Diseases and Venous Thromboembolism Diagnosis and Management.

Hormonal Regulation and …1Hormonal Regulation and Hypertension: 1 fractional worksSteroid Chemistry and Biochemistry: 0 fractional worksAntiplatelet Therapy and Cardiovascular Diseases: 0 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional worksCoronary Interventions a…0Coronary Interventions and Diagnostics: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksPlatelet Disorders and Treatments: 0 fractional worksAdrenal Hormones and Disorders: 0 fractional works
Endocrinology, Diabetes and MetabolismMolecular BiologyCardiology and Cardiovascular MedicineInternal Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 1 works
  2. 2 Steroid Chemistry and Biochemistry Molecular Biology 0 works
  3. 3 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
  4. 4 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  5. 5 Coronary Interventions and Diagnostics Surgery 0 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  7. 7 Lipoproteins and Cardiovascular Health Surgery 0 works
  8. 8 Platelet Disorders and Treatments Hematology 0 works
  9. 9 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.7%not open72.3%

World: 28% of research is openly available.

with international co-authors14.9%domestic only85.1%

World: 19% is written across borders.

How has PhaseBio Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 128% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Malvern

All research institutions in Malvern

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.